BrightView

What BrightView does

BrightView Health is a Cincinnati, Ohio-based outpatient addiction treatment provider founded in 2015 that operates more than 70 treatment centers across five U.S. states (Ohio, Kentucky, Virginia, Maryland, and North Carolina) and serves over 20,000 patients in active care with a team of approximately 1,200 clinicians, counselors, and support staff. The company's core offering is an integrated outpatient treatment platform that combines medication-assisted treatment (MAT) using FDA-approved medications such as buprenorphine products (Suboxone, Sublocade), methadone, naltrexone (Vivitrol), acamprosate (Campral), and disulfiram (Antabuse) with evidence-based behavioral therapies including cognitive behavioral therapy and motivational interviewing, alongside case management and social support services addressing housing, employment, and legal needs.

Its core technology and operating model emphasize same-day/next-day treatment access — most patients begin medication and counseling within four hours of first contact — and a modular product suite that includes a gold-standard Opioid Treatment Program (OTP) with on-site medication dispensing, a dedicated Behavioral Health Therapy line, LGBTQIA+-affirming care, and telehealth at select locations. The company holds the Joint Commission Gold Seal of Approval and is Great Place to Work Certified, with integrated multidisciplinary care teams and dedicated executive leadership across Compliance, Regulatory Affairs, Quality Operations, and Revenue Cycle Management.

BrightView generates revenue primarily by billing Medicaid, Medicare, and commercial insurance plans for outpatient MAT, counseling, and case management, supplemented by a monthly self-pay option for uninsured patients. Its go-to-market is dual-track: direct-to-consumer acquisition via a 24/7 phone line, online scheduling, and walk-in availability, alongside a referral channel drawing from primary care, hospitals, emergency departments, behavioral health professionals, and justice system partners. The company has executed a programmatic expansion strategy through acquisitions of Column Health (August 2022) and Corebella Health & Wellness (February 2023), and signals continued scaling through dedicated VP-level Growth, Development, and Transformation roles.

Name

BrightView

Legal name

BrightView, LLC

Website

https://brightviewhealth.com

Company type

Public

Founded year

2015

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BrightView Health operates 70+ outpatient addiction treatment centers across five U.S. states, delivering medication-assisted treatment, behavioral health therapy, and social support services to over 20,000 patients annually with same-day access and broad insurance acceptance.

Ownership category

akta.pro rank

Product category

Outpatient Addiction Treatment

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

akta.pro secondary industry

Medication-Assisted Treatment (MAT) & Opioid Treatment Programs (OTPs) (HLAFACAG)

Keywords

• Outpatient addiction treatment
• Medication-assisted treatment
• Substance use disorder care
• Behavioral health therapy
• Opioid treatment programs

Headquarters

HQ city

Cincinnati

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Insurance Billing: Revenue from billing Medicaid, Medicare, and commercial insurance plans for outpatient addiction treatment services including MAT, counseling, and case management.
2. Self-Pay/Out-of-Pocket: Monthly self-pay option for patients without insurance coverage, with payment plans available.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels7 records

Core offering

BrightView Health provides outpatient addiction treatment combining FDA-approved Medication-Assisted Treatment (MAT) with individual and group counseling, behavioral therapies, and social support services. Patients are treated for alcohol, opioid, fentanyl, heroin, stimulant, depressant, and marijuana use disorders through personalized care plans delivered at 70+ centers across five states (Ohio, Kentucky, Virginia, Maryland, North Carolina), with same-day access typically within four hours of first contact.

Product overview

BrightView offers an integrated outpatient addiction treatment platform combining Medication-Assisted Treatment (MAT), individual and group counseling, and social support services. The core Outpatient Treatment Program serves as the main delivery model, with specialized modules including the Opioid Treatment Program (OTP), Behavioral Health Therapy, and LGBTQIA+-affirming care. Treatment is personalized and may include FDA-approved medications such as buprenorphine products (Suboxone, Sublocade), methadone, naltrexone (Vivitrol), acamprosate (Campral), and disulfiram (Antabuse). Telehealth Services provide virtual access at select locations. The company operates 70+ treatment centers across five states with over 1,200 team members supporting 20,000+ patients in active care.

Differentiator

Problem solved

Functional benefit

Products and services

• Outpatient Addiction Treatment Program

Quantifiable outcome

• 44% decrease in illicit substance use after 90 days of treatment
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• The VillagescoreStrategic or Co-development Partner · 18 February 2026BrightView expanded its partnership with The Villages to manage golf courses. The partnership extension demonstrates BrightView's capabilities in golf course management services.
• Column HealthcoreStrategic or Co-development Partner · 4 August 2022Column Health, which operated addiction treatment clinics in Massachusetts, was acquired by BrightView Health in August 2022. This acquisition expanded BrightView's geographic footprint into Massachusetts and brought Column Health's evidence-based addiction treatment model into the BrightView network.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• BayMark Health Services: Largest US provider of office-based opioid treatment and methadone maintenance, operating a multi-state network of OTPs and MAT clinics. Most directly comparable to BrightView in service mix (MAT, OTP, counseling) and multi-state outpatient delivery model.
• CleanSlate Outpatient Addiction Medicine: Multi-state outpatient MAT provider focused on office-based buprenorphine treatment for opioid and alcohol use disorder. Directly comparable outpatient model, payer mix, and target patient population.
• American Addiction Centers: Public addiction-treatment operator offering inpatient, residential, and outpatient services across multiple states. Comparable patient population and integrated MAT + therapy model, with broader acuity mix.
• Pegasus Health: Multi-state outpatient MAT provider offering buprenorphine-based treatment and counseling services. Directly comparable office-based opioid treatment model and target patient population.

Broad incumbents

• Acadia Healthcare: Public behavioral-health operator with inpatient psychiatric and residential treatment facilities as well as expanding outpatient services. Overlaps in SUD treatment delivery and referral networks at greater scale.
• Hazelden Betty Ford Foundation: Established nonprofit addiction treatment provider with residential programs and outpatient services. Overlaps in evidence-based MAT, behavioral therapy, and multi-state clinical footprint.
• Caron Treatment Centers: Nonprofit addiction treatment provider with residential, outpatient, and MAT services across multiple states. Comparable whole-person care model with overlapping patient populations in the Eastern US.

Regional players

• Pyramid Healthcare: Regional addiction and behavioral-health provider in the Mid-Atlantic and Northeast offering MAT, residential, and outpatient programs. Comparable integrated SUD model with regional overlap to BrightView's footprint.

Emerging players

• Eleanor Health: Value-based outpatient addiction and mental-health provider with a multi-state clinic footprint and significant payer partnerships. Comparable outpatient MAT-plus-therapy model targeting Medicaid and commercial populations.
• Addiction Campuses: Multi-state addiction treatment operator offering residential, partial hospitalization, and outpatient services including MAT. Overlaps in integrated SUD care model across multiple state geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@brightviewhealth
• Facebookfacebook.com/brightviewtreatment
• LinkedInlinkedin.com/company/brightview-llc
• Instagraminstagram.com/brightview_health
• Xx.com/BrightViewHlth

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BrightView